Notification
Mycryptopot
  • Home
  • News
  • Crypto
    • Altcoins
    • Bitcoin
    • Blockchain
    • Cardano
    • Ethereum
    • Nft
    • Solana
    • XRP
    • Tron
  • MarketCap
  • Market
  • Forex
  • Mining
  • Metaverse
  • Exchange
  • Regulations
  • Analysis
    • Crypto Bubbles
    • Multi Currency
    • Evaluation
Reading: Moderna Stock Surges 145% Today, How High Can MRNA Go?
Share
bitcoin
Bitcoin (BTC) $ 62,099.00
ethereum
Ethereum (ETH) $ 1,752.19
tether
Tether (USDT) $ 0.998928
bnb
BNB (BNB) $ 575.81
usd-coin
USDC (USDC) $ 0.999552
xrp
XRP (XRP) $ 0.957039
binance-usd
BUSD (BUSD) $ 0.998601
dogecoin
Dogecoin (DOGE) $ 0.057775
cardano
Cardano (ADA) $ 0.148591
solana
Solana (SOL) $ 72.40
polkadot
Polkadot (DOT) $ 0.704237
tron
TRON (TRX) $ 0.308468
MycryptopotMycryptopot
Search
  • Home
  • News
  • Crypto
    • Altcoins
    • Bitcoin
    • Blockchain
    • Cardano
    • Ethereum
    • Nft
    • Solana
    • XRP
    • Tron
  • MarketCap
  • Market
  • Forex
  • Mining
  • Metaverse
  • Exchange
  • Regulations
  • Analysis
    • Crypto Bubbles
    • Multi Currency
    • Evaluation
© 2024 All Rights reserved | Powered by Crypto My Crypto Pot
Mycryptopot > News > Crypto > Solana > Moderna Stock Surges 145% Today, How High Can MRNA Go?
Solana

Moderna Stock Surges 145% Today, How High Can MRNA Go?

August 19, 2026 3 Min Read
Share
Moderna Stock MRNA

Biotech firm Moderna (MRNA) has issued a promising replace Wednesday, revealing that its most cancers vaccine reveals indicators of stopping melanoma from spreading. The information sparked a major rally for MRNA inventory by as a lot as 145%, far exceeding different shares available on the market.

In line with Moderna, a customized mRNA most cancers vaccine decreased the ​threat of recurrence and unfold of melanoma in a late-stage trial, a serious success in a brand new area of most cancers therapy that despatched the drugmaker’s ‌shares surging as a lot as 160%. Moderna developed the vaccine with Merck and examined it along with immunotherapy drug Keytruda, a broadly used therapy for melanoma. Hundreds of sufferers who’ve undergone surgical procedure to take away high-risk melanoma tumors may gain advantage as quickly as subsequent yr if regulators approve the vaccine, Moderna President Stephen Hoge mentioned in an interview.

“At present’s outcomes symbolize a landmark second for adjuvant melanoma therapy. That is the primary Part 3 examine to indicate that intismeran, a therapy designed based mostly on the distinctive mutational ‘fingerprint’ of a affected person’s personal tumor, given together with pembrolizumab can cut back the chance of recurrence or demise in sufferers with utterly resected stage IIB-IV melanoma in comparison with KEYTRUDA alone,” mentioned Professor Georgina Lengthy, the examine’s principal investigator and medical director of Melanoma Institute Australia, Chair of Melanoma Medical Oncology and Translational Analysis on the College of Sydney. “Intismeran together with pembrolizumab has the potential to ascertain a brand new therapy paradigm within the adjuvant melanoma setting, serving to sufferers stay cancer-free for longer.”

The trial outcomes attracted new investor curiosity within the biotech sector broadly. The Nasdaq Biotechnology Index (.NBI) climbed 4.4% to a report excessive, beating out the S&P 500 index and Nasdaq index. Moreover, the outcomes additionally signaled a reversal of fortune for Moderna, which has struggled to generate new merchandise past its COVID-19 vaccine and confronted pushback over its mRNA ​know-how from President Donald Trump’s administration. Moderna shares surged to multiyear highs, including practically $40 billion to the corporate’s market capitalization. Merck climbed 11% on hopes the vaccine will broaden its prospects in most cancers analysis.

You Might Also Like

Why Are They All In on NVIDIA Despite China Risk & Massive Growth

G20 to Develop Regulatory Framework for Crypto and Stablecoins

Solana’s 7% Surge: Is Now the Time to Invest?

2 Countries Express Interest to Join BRICS Alliance in 2026

Supermicro Stock (SMCI): Stock Crashes 27% After CEO Charged

TAGGED:SolanaStocks
Share This Article
Facebook Twitter Copy Link
Previous Article Hashdex liquidates $14.7 million Bitcoin ETF as IBIT draws $143.6 million Hashdex liquidates $14.7 million Bitcoin ETF as IBIT draws $143.6 million
Next Article image Coinbase-Circle USDC collaboration, FOMC minutes, oil price: Crypto Week Ahead
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

- Advertisement -

Popular News

SONEX launches on Soneium’s mainnet 
SONEX launches on Soneium’s mainnet 
Tangle Network Partners with Orochi Network to Advance Blockchain Capabilities
Tangle Network Partners with Orochi Network to Advance Blockchain Capabilities
A yellow cart bearing the Bitcoin symbol stands before four concrete test bays in an overhead collage.
Bitcoin launches Testnet5 and gives miners a real trial of four proposed fixes
Blue and yellow canvas shields stand under dark storm clouds. The near blue shield bears the Bitcoin symbol.
Bitcoin options flash warning as downside premiums surge ahead of Fed minutes
A stack of worn folders fills one Bitcoin-marked cubby in a turquoise and orange rack beside empty compartments.
Bitcoin buyers pile 66,000 BTC into critical $62,000 support zone
A wooden cart marked with the Bitcoin symbol sits on a curved track below a spring whose connection to the cart is sketched beside a question mark. Torn clippings show a line chart, “reversion,” and “820 weekly observations.”
Bitcoin power-law models predict a rebound without real proof
- Advertisement -

You Might Also Like

Bloomberg analysts revise ETF approval odds to ‘90% or higher’ as SEC requests amended filings
Solana

Bloomberg analysts revise ETF approval odds to ‘90% or higher’ as SEC requests amended filings

June 20, 2025
bitcoin btc up rally green
Solana

Mark Moss Reveals the Bitcoin Amount Needed for True Financial Freedom

December 3, 2025
US Congressman George Santos
Solana

Visa (V), Mastercard, and Stripe to Launch Crypto Stablecoin

June 3, 2026
JPMorgan taps both Ethereum and Solana for separate reasons for its institutional cash stack
Solana

JPMorgan taps both Ethereum and Solana for separate reasons for its institutional cash stack

May 13, 2026
Mycryptopot

"Welcome to MyCryptoPot, your go-to source for the latest insights and developments in the ever-evolving world of cryptocurrency.

Editor Choice

Circle’s USDC is leaving Tether behind in the stablecoin volume race, new data from Visa shows
BNB Price Reacts as BSC Crosses 2,000,000,000 Address Milestone
DTX Exchange Is Trading Like This Cycle’s Dogecoin, Shocking Similarity Emerges Between 2021 DOGE Chart

Follow Us on Socials

We use social media to react to breaking news, update supporters and share information

Facebook Twitter Telegram
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service
Reading: Moderna Stock Surges 145% Today, How High Can MRNA Go?
Share
© 2024 All Rights reserved | Powered by Crypto My Crypto Pot
Welcome Back!

Sign in to your account

Lost your password?